PAR · —
Aelis Farma SA (AELIS.PA) Stock
$1.07
+4.90%
PAR: AELIS.PA
—
—
Valuation
Financials & Margins
Latest News
2 Surging Stocks for Long-Term Investors and 1 That Underwhelm
StockStory · Aug 14, 2026
TestMu AI Unveils the Fifth Edition of the TestMu Conference in 2026
CNW Group · Aug 14, 2026
Ameren Corporation Directors Declare Quarterly Dividend
PR Newswire · Aug 14, 2026
Stock Market Midday, Aug. 14: Stocks Wobble on Falling Consumer Confidence, Reddit Jumps 14%
Motley Fool · Aug 14, 2026
Aehr Test Systems' CEO Sells Shares Worth $5.2 Million After a 564% Rally in Price. Here's a Closer Look at the Transaction.
Motley Fool · Aug 14, 2026
Valuation & Return Ratios
Ownership
Insiders Held36.44%
Institutions Held27.52%
Institutions Float Held43.29%
Peer Comparison
About Aelis Farma SA
—
Aelis Farma SA is led by CEO Pier Vincenzo Piazza, employs 16 people, headquartered in Bordeaux, FR, publicly traded since 2022.
Aelis Farma SA (AELIS.PA) stock trades at $1.07 with a market capitalization of $14.59M. The stock is valued at a price-to-earnings (P/E) ratio of -2.28, price-to-book of 3.28, price-to-sales of 7.00. Over the past 52 weeks the stock has ranged between $0.95 and $2.30, and currently trades 53.5% below its 52-week high.
On profitability, Aelis Farma SA generates a return on equity (ROE) of -88.41%, an operating margin of -172.75%, a net profit margin of 0.00%.
Official website: www.aelisfarma.com